Pre-diagnostic acrylamide exposure and survival after breast cancer among postmenopausal Danish women

Toxicology

Volumn 296, Issue 1-3, 2012, Pages 67-72

  Olsen, Anja ^a   Christensen, Jane ^a   Outzen, Malene ^a   Olesen, Pelle Thonning ^b   Frandsen, Henrik ^b   Overvad, Kim ^c,d   Halkjær, Jytte ^a  

^a DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^b TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^c AARHUS UNIVERSITY   (Denmark)

^d AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Acrylamide; Breast cancer survival; Glycidamide; Hemoglobin adducts

Indexed keywords

ACRYLAMIDE; ESTROGEN RECEPTOR; GLYCIDAMIDE; HEMOGLOBIN;

ADULT; ARTICLE; BLOOD SAMPLING; BREAST CANCER; CANCER MORTALITY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ACRYLAMIDE; AGED; BIOLOGICAL MARKERS; BREAST NEOPLASMS; DENMARK; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; EPOXY COMPOUNDS; FEMALE; HEMOGLOBINS; HUMANS; MIDDLE AGED; POSTMENOPAUSE; RISK FACTORS;

ANIMALIA; NICOTIANA TABACUM;

EID: 84859985382     PISSN: 0300483X     EISSN: 18793185     Source Type: Journal    
DOI: 10.1016/j.tox.2012.03.004     Document Type: Article

References (38)

1. Barnett G.C., Shah M., Redman K., Easton D.F., Ponder B.A., Pharoah P.D. Risk factors for the incidence of breast cancer: do they affect survival from the disease?. J. Clin. Oncol. 2008, 26:3310-3316.
2. Bergmark E. Hemoglobin adducts of acrylamide and acrylonitrile in laboratory workers smokers and nonsmokers. Chem. Res. Toxicol. 1997, 10:78-84.
3. Besaratinia A., Pfeifer G.P. A review of mechanisms of acrylamide carcinogenicity. Carcinogenesis 2007, 28:519-528.
4. Bjellaas T., Olesen P.T., Frandsen H., Haugen M., Stolen L.H., Paulsen J.E., Alexander J., Lundanes E., Becher G. Comparison of estimated dietary intake of acrylamide with hemoglobin adducts of acrylamide and glycidamide. Toxicol. Sci. 2007, 98:110-117.
5. Calleman C.J., Bergmark E., Costa L.G. Acrylamide is metabolized to glycidamide in the rat: evidence from hemoglobin adduct formation. Chem. Res. Toxicol. 1990, 3:406-412.
6. Carlsen K., Hoybye M.T., Dalton S.O., Tjonneland A. Social inequality and incidence of and survival from breast cancer in a population-based study in Denmark, 1994-2003. Eur. J. Cancer 2008, 44:1996-2002.
7. Catalgol B., Ozhan G., Alpertunga B. Acrylamide-induced oxidative stress in human erythrocytes. Hum. Exp. Toxicol. 2009, 28:611-617.
8. Dal M.L., Zucchetto A., Talamini R., Serraino D., Stocco C.F., Vercelli M., Falcini F., Franceschi S. Effect of obesity and other lifestyle factors on mortality in women with breast cancer. Int. J. Cancer 2008, 123:2188-2194.
9. Doroshyenko O., Fuhr U., Kunz D., Frank D., Kinzig M., Jetter A., Reith Y., Lazar A., Taubert D., Kirchheiner J., Baum M., Eisenbrand G., Berger F.I., Bertow D., Berkessel A., Sorgel F., Schomig E., Tomalik-Scharte D. In vivo role of cytochrome P450 2E1 and glutathione-S-transferase activity for acrylamide toxicokinetics in humans. Cancer Epidemiol. Biomarkers Prev. 2009, 18:433-443.
10. Fischerman K., Mouridsen H.T. Danish Breast Cancer Cooperative Group (DBCG). Structure and results of the organization. Acta Oncol. 1988, 27:593-596.
11. Folkerd E.J., Dowsett M. Influence of sex hormones on cancer progression. J. Clin. Oncol. 2010, 28:4038-4044.
12. Friedman M.A., Dulak L.H., Stedham M.A. A lifetime oncogenicity study in rats with acrylamide. Fundam. Appl. Toxicol. 1995, 27:95-105.
13. Ghanayem B.I., McDaniel L.P., Churchwell M.I., Twaddle N.C., Snyder R., Fennell T.R., Doerge D.R. Role of CYP2E1 in the epoxidation of acrylamide to glycidamide and formation of DNA and hemoglobin adducts. Toxicol. Sci. 2005, 88:311-318.
14. Hartmann E.C., Latzin J.M., Schindler B.K., Koch H.M., Angerer J. Excretion of 2,3-dihydroxy-propionamide (OH-PA), the hydrolysis product of glycidamide, in human urine after single oral dose of deuterium-labeled acrylamide. Arch. Toxicol. 2010, 86:601-606.
15. Hecht S.S. Tobacco smoke carcinogens and breast cancer. Environ. Mol. Mutagen. 2002, 39:119-126.
16. Hogervorst J.G., Baars B.J., Schouten L.J., Konings E.J., Goldbohm R.A., van den Brandt P.A. The carcinogenicity of dietary acrylamide intake: a comparative discussion of epidemiological and experimental animal research. Crit. Rev. Toxicol. 2010, 40:485-512.
17. Hogervorst J.G., Schouten L.J., Konings E.J., Goldbohm R.A., van den Brandt P.A. A prospective study of dietary acrylamide intake and the risk of endometrial, ovarian, and breast cancer. Cancer Epidemiol. Biomarkers Prev. 2007, 16:2304-2313.
18. IARC Tobacco smoking. IARC Monogr. Eval. Carcinog. Risk Chem. Hum. 1986, 38:35-394.
19. IARC IARC Monographs on the Evaluation of Carcinogenic Risks to Humans - Some Industrial Chemicals, Report 60 1994, International Agency for Research on Cancer, Lyon, France.
20. JECFA, 2005. Summary and conclusions of the 64th meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA). Rome, Italy.
21. Johnson K.A., Gorzinski S.J., Bodner K.M., Campbell R.A., Wolf C.H., Friedman M.A., Mast R.W. Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. Toxicol. Appl. Pharmacol. 1986, 85:154-168.
22. Kendall A., Folkerd E.J., Dowsett M. Influences on circulating oestrogens in postmenopausal women: relationship with breast cancer. J. Steroid Biochem. Mol. Biol. 2007, 103:99-109.
23. Kopp E.K., Dekant W. Toxicokinetics of acrylamide in rats and humans following single oral administration of low doses. Toxicol. Appl. Pharmacol. 2009, 235:135-142.
24. Liedtke S., Schmidt M.E., Vrieling A., Lukanova A., Becker S., Kaaks R., Zaineddin A.K., Buck K., Benner A., Chang-Claude J., Steindorf K. Postmenopausal sex hormones in relation to body fat distribution. Obesity (Silver Spring) 2012, [Epub ahead of print].
25. Olesen P.T., Olsen A., Frandsen H., Frederiksen K., Overvad K., Tjonneland A. Acrylamide exposure and incidence of breast cancer among postmenopausal women in the Danish Diet, Cancer and Health Study. Int. J. Cancer 2008, 122:2094-2100.
26. Paulsson B., Athanassiadis I., Rydberg P., Tornqvist M. Hemoglobin adducts from glycidamide: acetonization of hydrophilic groups for reproducible gas chromatography/tandem mass spectrometric analysis. Rapid Commun. Mass Spectrom. 2003, 17:1859-1865.
27. Paulsson B., Granath F., Grawe J., Ehrenberg L., Tornqvist M. The multiplicative model for cancer risk assessment: applicability to acrylamide. Carcinogenesis 2001, 22:817-819.
28. Pedersen G.S., Hogervorst J.G., Schouten L.J., Konings E.J., Goldbohm R.A., van den Brandt P.A. Dietary acrylamide intake and estrogen and progesterone receptor-defined postmenopausal breast cancer risk. Breast Cancer Res. Treat. 2010, 122:199-210.
29. Storm H.H., Michelsen E.V., Clemmensen I.H., Pihl J. The Danish Cancer Registry - history content, quality and use. Dan. Med. Bull. 1997, 44:535-539.
30. Sumner S.C., Fennell T.R., Moore T.A., Chanas B., Gonzalez F., Ghanayem B.I. Role of cytochrome P450 2E1 in the metabolism of acrylamide and acrylonitrile in mice. Chem. Res. Toxicol. 1999, 12:1110-1116.
31. Tareke E., Rydberg P., Karlsson P., Eriksson S., Tornqvist M. Acrylamide: a cooking carcinogen?. Chem. Res. Toxicol. 2000, 13:517-522.
32. Tareke E., Twaddle N.C., McDaniel L.P., Churchwell M.I., Young J.F., Doerge D.R. Relationships between biomarkers of exposure and toxicokinetics in Fischer 344 rats and B6C3F1 mice administered single doses of acrylamide and glycidamide and multiple doses of acrylamide. Toxicol. Appl. Pharmacol. 2006, 217:63-75.
33. Terry P.D., Rohan T.E. Cigarette smoking and the risk of breast cancer in women: a review of the literature. Cancer Epidemiol. Biomarkers Prev. 2002, 11:953-971.
34. Tjonneland A., Olsen A., Boll K., Stripp C., Christensen J., Engholm G., Overvad K. Study design, exposure variables, and socioeconomic determinants of participation in Diet, Cancer and Health: a population-based prospective cohort study of 57,053 men and women in Denmark. Scand. J. Public Health 2007, 35:432-441.
35. Urban M., Kavvadias D., Riedel K., Scherer G., Tricker A.R. Urinary mercapturic acids and a hemoglobin adduct for the dosimetry of acrylamide exposure in smokers and nonsmokers. Inhal. Toxicol. 2006, 18:831-839.
36. Vesper H.W., Slimani N., Hallmans G., Tjonneland A., Agudo A., Benetou V., Bingham S., Boeing H., Boutron-Ruault M.C., Bueno-de-Mesquita H.B., Chirlaque D., Clavel-Chapelon F., Crowe F., Drogan D., Ferrari P., Johansson I., Kaaks R., Linseisen J., Lund E., Manjer J., Mattiello A., Palli D., Peeters P.H., Rinaldi S., Skeie G., Trichopoulou A., Vineis P., Wirfalt E., Overvad K., Stromberg U. Cross-sectional study on acrylamide hemoglobin adducts in subpopulations from the European Prospective Investigation into Cancer and Nutrition (EPIC) Study. J. Agric. Food Chem. 2008, 56:6046-6053.
37. Wilson K.M., Mucci L.A., Rosner B.A., Willett W.C. A prospective study on dietary acrylamide intake and the risk for breast, endometrial, and ovarian cancers. Cancer Epidemiol. Biomarkers Prev. 2010, 19:2503-2515.
38. Wilson K.M., Vesper H.W., Tocco P., Sampson L., Rosen J., Hellenas K.E., Tornqvist M., Willett W.C. Validation of a food frequency questionnaire measurement of dietary acrylamide intake using hemoglobin adducts of acrylamide and glycidamide. Cancer Causes Control 2009, 20:269-278.